Here is one surgeon who publishes figures that differ significantly from the ones in this study..
Nearly 95% of all organ-confined ART™ patients receive a negative surgical margin (no cancer is found on the specimen surface) on their surgical pathology report. In published long term follow-up studies performed by Dr. Tewari, this cancer control can translate to an over 90% 10-year survival rate in select patients.
ART™ prostate surgery is minimally invasive. The instruments used are inserted through very small openings [more about ART™], transfusions are rare, pain medication is required sparingly, if at all, and the typical hospital stay is just 24 hours. The patient is discharged with instructions to get plenty of walking exercise and typically returns to our office seven days after discharge from the hospital to have his urinary catheter removed– in a five-minute outpatient procedure. Catheter removal may also be performed by the patient's regular urologist, should the patient be unable to return to Dr. Tewari's office.
Recovering After Surgery
The ART™ robotic surgical method is remarkable for its success in minimizing the effects treatment may have on bowel, urinary, and sexual functioning.
* Bowel symptoms, which can be a troublesome side effect of radiation treatment, are experienced by less than 2% of ART™ patients.
* Fully 87% of patients who experienced normal sexual functioning before surgery, and are candidates for nerve sparing, returned to function after ART™ surgical treatment.
* Recovery of urinary continence, which may be problematic any prostatectomy, is also improved with robotic surgery. Dr. Tewari's pioneering technique of bladder support reconstruction, a standard component of the ART™ procedure, is achieving continence in 80% of his patients at 1 month after surgery, and in 97% of his patients at 6 months after surgery!
PSA age 55: 3.5, DRE normal.
age 58: 4.5
64: 7.5, DRE "Abnormal"
65: 8.5, " normal", biopsy, 12 core, negative...
66 9.0 "normal", 2ed biopsy, negative, BPH, Proscar
67 4.5 DRE "normal"
68 7.0 3rd biopsy positive, 4 out of 12, G-6,7, 9
RALP Sept 3 2010, pos margin, one pos vesicle nodes neg. Post Op PSA 0.9 SRT, HT. 2-15-'11 PSA 0.0